Michael Maeng Selected Research

ST Elevation Myocardial Infarction

11/2023	Bleeding risk and P2Y12 inhibitors in all-comer patients with ST-segment elevation myocardial infarction treated with percutaneous coronary intervention: a single-centre cohort study.
1/2023	Mortality Trends After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction.
1/2023	Real-World Experience with Cangrelor as Adjuvant to Percutaneous Coronary Intervention: A Single-Centre Observational Study.
1/2022	Early vascular healing after implantation of the polymer-free biolimus-eluting stent or the ultrathin strut biodegradable polymer sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction.
1/2021	Instantaneous wave-free ratio guided multivessel revascularisation during percutaneous coronary intervention for acute myocardial infarction: study protocol of the randomised controlled iMODERN trial.
12/2020	Culprit lesion morphology in patients with ST-segment elevation myocardial infarction assessed by optical coherence tomography.
3/2020	Angiographic and clinical outcomes of STEMI patients treated with bioresorbable or metallic everolimus-eluting stents: a pooled analysis of individual patient data.
1/2020	16-year follow-up of the Danish Acute Myocardial Infarction 2 (DANAMI-2) trial: primary percutaneous coronary intervention vs. fibrinolysis in ST-segment elevation myocardial infarction.
1/2020	Interaction of ischaemic postconditioning and thrombectomy in patients with ST-elevation myocardial infarction.
10/2019	Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Maeng Research Topics

Disease

82	Myocardial Infarction 03/2024 - 05/2004
70	Thrombosis (Thrombus) 12/2023 - 10/2006
41	Death (Near-Death Experience) 12/2023 - 10/2006
33	ST Elevation Myocardial Infarction 11/2023 - 07/2006
32	Cardiovascular Diseases (Cardiovascular Disease) 03/2024 - 10/2006
23	Hemorrhage 03/2024 - 04/2014
19	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023 - 02/2009
18	Diabetes Mellitus 01/2022 - 07/2008
14	Acute Coronary Syndrome 12/2023 - 10/2012
14	Ischemic Stroke 01/2023 - 03/2012
11	Stroke (Strokes) 01/2022 - 04/2014
10	Atrial Fibrillation 10/2023 - 10/2017
9	Pathologic Constriction (Stenosis) 11/2020 - 10/2003
7	Hyperplasia 01/2023 - 07/2008
6	Myocardial Ischemia (Ischemic Heart Diseases) 03/2024 - 09/2003
6	Heart Failure 12/2022 - 01/2017
6	Infarction (Infarctions) 01/2017 - 05/2004
4	Atherosclerotic Plaque (Atheroma) 12/2023 - 11/2020
4	Type 2 Diabetes Mellitus (MODY) 01/2023 - 07/2009
4	Coronary Occlusion 09/2005 - 01/2003
3	Unstable Angina 12/2023 - 11/2011
3	Peripheral Arterial Disease 10/2022 - 10/2019
3	Stable Angina 12/2021 - 10/2012
3	Coronary Stenosis (Coronary Artery Stenosis) 01/2018 - 01/2010
3	Ischemia 07/2009 - 03/2006
2	Chest Pain (Chest Pains) 12/2023 - 01/2023
2	Inflammation (Inflammations) 01/2023 - 03/2013
2	Thromboembolism 10/2022 - 01/2020
2	Coronary Disease (Coronary Heart Disease) 12/2021 - 02/2016
2	COVID-19 01/2021 - 10/2020
2	Angina Pectoris 05/2019 - 08/2012
2	Embolism (Embolus) 01/2019 - 10/2017
2	Non-ST Elevated Myocardial Infarction 01/2019 - 09/2012
2	Neointima 01/2018 - 09/2004
1	Overweight 03/2024
1	Rupture 12/2023
1	Hyperinsulinism (Hyperinsulinemia) 01/2023
1	Insulin Resistance 01/2023
1	Liver Diseases (Liver Disease) 10/2022
1	Pulmonary Hypertension 07/2022
1	Renal Insufficiency (Renal Failure) 01/2022
1	Heart Diseases (Heart Disease) 01/2022
1	Dementia (Dementias) 01/2022
1	Acute Kidney Injury (Acute Renal Failure) 01/2022
1	Venous Thromboembolism 01/2022

Drug/Important Bio-Agent (IBA)

31	omega-Chloroacetophenone (Mace)IBA 03/2024 - 05/2011
26	Sirolimus (Rapamycin)FDA Link 01/2023 - 07/2008
11	Everolimus FDA Link 03/2022 - 03/2012
10	Clopidogrel (Plavix)FDA Link 11/2023 - 03/2012
9	zotarolimusIBA 01/2020 - 03/2010
8	MetalsIBA 06/2022 - 07/2007
7	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2022 - 10/2017
6	PolymersIBA 12/2023 - 02/2013
6	Paclitaxel (Taxol)FDA LinkGeneric 10/2011 - 07/2008
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2024 - 11/2022
5	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 11/2023 - 01/2016
4	LDL CholesterolIBA 01/2024 - 01/2022
4	TicagrelorIBA 11/2023 - 10/2017
4	BESIBA 01/2022 - 01/2019
3	oxidized low density lipoproteinIBA 01/2024 - 01/2022
3	LipidsIBA 12/2023 - 11/2020
3	AnticoagulantsIBA 10/2023 - 06/2019
3	CalciumIBA 10/2022 - 12/2021
3	Warfarin (Coumadin)FDA LinkGeneric 12/2021 - 10/2017
3	Dabigatran FDA Link 12/2021 - 10/2017
3	Phenobarbital (Luminal)FDA Link 03/2016 - 10/2003
2	HDL CholesterolIBA 03/2024 - 01/2024
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 10/2023 - 10/2017
2	Troponin T (Troponin T1)IBA 01/2023 - 07/2006
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 02/2015
2	Triglycerides (Triacylglycerol)IBA 01/2023 - 10/2022
2	Vitamin K FDA Link 10/2022 - 01/2022
2	insulin receptor-related receptor (IRR)IBA 01/2022 - 01/2019
2	N- acetyl- S- (alpha- methyl- 4- (2- methylpropyl)benzeneacetyl)cysteine 4-(nitrooxy)butyl esterIBA 12/2021 - 10/2017
2	Angiotensin Receptor AntagonistsIBA 01/2021 - 10/2020
2	Insulin (Novolin)FDA Link 01/2021 - 01/2019
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 10/2020
2	Stainless Steel (Steel, Stainless)IBA 01/2020 - 01/2019
2	Tissue Plasminogen Activator (Alteplase)FDA Link 07/2009 - 05/2008
2	Erythropoietin FDA Link 09/2006 - 09/2005
1	semaglutideIBA 03/2024
1	Troponin IIBA 12/2023
1	Indicators and Reagents (Reagents)IBA 12/2023
1	Prasugrel Hydrochloride FDA Link 11/2023
1	C-PeptideIBA 01/2023
1	C-Reactive ProteinIBA 01/2023
1	cangrelorIBA 01/2023
1	TroponinIBA 01/2023
1	eicosapentaenoic acid ethyl esterIBA 10/2022

Therapy/Procedure

96	Stents 12/2023 - 10/2003
50	Percutaneous Coronary Intervention 12/2023 - 07/2006
30	Therapeutics 03/2024 - 05/2004
25	Drug-Eluting Stents 04/2022 - 11/2008
5	Catheters 11/2020 - 01/2003
3	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2021 - 10/2013
3	Thrombectomy 01/2020 - 07/2006
3	Patient Readmission 01/2020 - 09/2014
2	Surgical Amputation (Amputations) 10/2022 - 01/2021
2	Operative Surgical Procedures 12/2021 - 01/2019
1	Endarterectomy (Thromboendarterectomy) 07/2022